|

Regadenoson Clinical Trials

1 actively recruiting trial

Also known as: Rapiscan

Pipeline

Phase 1/2: 1

Top Sponsors

  • GE Healthcare1

Indications

  • Myocardial Ischemia1
  • Heart Disease1
  • Coronary Artery Disease1

Other1 trial

A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.